ENG/中
美国
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerGPT
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
Prospect Capital Corp
25.06
+0.0000
成交量:
- -
成交額:
31.97萬
市值:
92.18億
市盈率:
68.17
高:
25.06
開:
25.06
低:
25.06
收:
25.06
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
Tharimmune, Inc.盤中異動 大幅下挫6.21%報1.36美元
市场透视
·
03-04
Tharimmune, Inc.盤中異動 下午盤快速上漲5.67%
市场透视
·
02-27
外媒:OpenAI輝煌時代已經結束
鞭牛士Bianews
·
02-19
Tharimmune, Inc.盤中異動 股價大跌6.02%
市场透视
·
01-25
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PBC"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBC\",,,,,undefined,":{"symbol":"PBC","market":"US","secType":"STK","nameCN":"Prospect Capital Corp","latestPrice":25.06,"timestamp":1640811600000,"preClose":25.06,"halted":4,"volume":0,"delay":0,"floatShares":0,"shares":367817926,"eps":0.367626,"marketStatus":"退市","change":0,"latestTime":"12-29 16:00:00 EST","open":25.06,"high":25.06,"low":25.06,"amount":319705.1613,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.367626,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1743408000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":25.06,"dividendRate":0.028731,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBC\",,,,,undefined,":{"symbol":"PBC","floatShares":0,"roa":"4.83%","roe":"4.16%","lyrEps":0.394789,"shares":367817926,"dividePrice":0.72,"high":25.06,"amplitude":0,"preClose":25.06,"low":25.06,"week52Low":25,"pbRate":"2.90","week52High":26.49,"institutionHeld":0,"latestPrice":25.06,"eps":0.367626,"divideRate":0.028731,"volume":0,"delay":0,"ttmEps":0.367626,"open":25.06},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PBC\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBC\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516670075","title":"Tharimmune, Inc.盤中異動 大幅下挫6.21%報1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516670075?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 22:32","pubTimestamp":1741098734,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分,Tharimmune, Inc.股票出现异动,股价快速下挫6.21%。截至发稿,该股报1.36美元/股,成交量56.5869万股,换手率29.26%,振幅0.69%。Tharimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。Tharimmune, Inc.公司简介:Tharimmune Inc 是一家生物技术公司,开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223214a25f049a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223214a25f049a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC","THAR","BK4139"],"gpt_icon":0},{"id":"2514686977","title":"Tharimmune, Inc.盤中異動 下午盤快速上漲5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514686977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514686977?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 03:02","pubTimestamp":1740596538,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时02分,Tharimmune, Inc.股票出现异动,股价大幅上涨5.67%。Tharimmune, Inc.股票所在的生物技术行业中,整体跌幅为0.74%。其相关个股中,Enveric Biosciences, Inc.、Renovaro Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大,Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃,换手率分别为6518.56%、288.25%、256.53%,振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Organovo Holdings, Inc.,振幅分别为194.07%、81.11%、52.76%。Tharimmune, Inc.公司简介:Tharimmune Inc 是一家生物技术公司,开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270302189631805d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270302189631805d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC","BK4139","THAR"],"gpt_icon":0},{"id":"2512662459","title":"外媒:OpenAI輝煌時代已經結束","url":"https://stock-news.laohu8.com/highlight/detail?id=2512662459","media":"鞭牛士Bianews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512662459?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 23:00","pubTimestamp":1739977239,"startTime":"0","endTime":"0","summary":"鞭牛士报道,2月19日消息,ITPro分析认为,OpenAI 的辉煌时代已经结束。OpenAI 曾经表现良好,但我认为,它备受关注的时代即将结束。目前尚不清楚此次重组将如何影响 OpenAI 的长期财务困境,但目前该公司的状况大致相同。例如,本月早些时候,竞争对手人工智能公司 Figure 宣布将终止与 OpenAI 的交易。这还有待观察,但很明显,OpenAI 不再是曾经的领跑者。DeepSeek 是该领域的新秀,它是一种全新的替代方案,让 OpenAI 看起来几乎过时了。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8h6rHRpjp8N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["LU2023250504.SGD","LU1116320901.HKD","LU2242650005.HKD","MSFT","LU2505996509.AUD","LU2092937221.SGD","SG9999015341.SGD","LU2213496289.HKD","LU2471134796.USD","LU0784385840.USD","IE00BN8TJ469.HKD","LU0310800379.SGD","BK4585","LU2360108059.USD","LU1564329461.SGD","LU0097036916.USD","LU1861127337.USD","SG9999014898.SGD","LU2360032135.SGD","LU1236620834.HKD","LU0080751232.USD","LU2041044095.USD","LU0149725797.USD","IE0004445239.USD","LU0894486033.HKD","LU0795875169.SGD","BK4532","LU0056508442.USD","LU1267930730.SGD","LU1043141396.HKD","LU0302445910.USD","LU0251132253.USD","IE00B19Z8W00.USD","LU0170899867.USD","LU0316494557.USD","LU2092627202.USD","LU0347712357.USD","LU0444971666.USD","LU2023250330.USD","LU2237443978.SGD","PBC","IE0003U64NQ7.SGD","BK4535","LU0203202063.USD","LU0053666078.USD","LU1914381329.SGD","BK4538","LU1791710400.SGD","LU1244550221.USD","IE00BJJMRY28.SGD"],"gpt_icon":1},{"id":"2506889898","title":"Tharimmune, Inc.盤中異動 股價大跌6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506889898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506889898?lang=zh_tw&edition=fundamental","pubTime":"2025-01-25 00:24","pubTimestamp":1737735891,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日00时24分,Tharimmune, Inc.股票出现异动,股价快速下挫6.02%。Tharimmune, Inc.股票所在的生物技术行业中,整体跌幅为0.06%。其相关个股中,Evaxion Biotech As、Neuphoria Therapeutics Inc.、Pmgc Holdings Inc.涨幅较大,Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为3872.49%、2103.81%、1560.72%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Neuphoria Therapeutics Inc.,振幅分别为134.08%、112.09%、107.98%。Tharimmune, Inc.公司简介:Tharimmune Inc 是一家生物技术公司,开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125002451abb76906&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125002451abb76906&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","PBC","BK4139"],"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":34}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-12-30","symbol":"PBC","reason":null,"defaultRemindTime":1640874600000,"announcedDate":"2021-12-01","type":"delisting","dateTimestamp":1640840400000},{"market":"US","date":"2021-11-30","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1638282600000,"name":"Prospect Capital Corp","recordDate":"2021-12-15","payableDate":"2021-12-01","currency":"USD","type":"dividend","dateTimestamp":1638248400000},{"market":"US","date":"2021-08-31","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1630416600000,"name":"Prospect Capital Corp","recordDate":"2021-09-15","payableDate":"2021-09-01","currency":"USD","type":"dividend","dateTimestamp":1630382400000},{"market":"US","date":"2021-05-28","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1622208600000,"name":"Prospect Capital Corp","recordDate":"2021-06-15","payableDate":"2021-06-01","currency":"USD","type":"dividend","dateTimestamp":1622174400000},{"market":"US","date":"2021-02-26","symbol":"PBC","amount":0.4296875,"name":"Prospect Capital Corp","recordDate":"2021-03-15","payableDate":"2021-03-01","currency":"USD","type":"dividend","dateTimestamp":1614315600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBC\",market:\"US\",,,undefined,":[{"executeDate":"2019-02-28","recordDate":"2019-03-01","paymentDate":"2019-03-15","value":0.4774306,"currency":"USD"},{"executeDate":"2019-08-29","recordDate":"2019-08-30","paymentDate":"2019-09-15","value":0.4296875,"currency":"USD"},{"executeDate":"2019-11-27","recordDate":"2019-11-29","paymentDate":"2019-12-15","value":0.4296875,"currency":"USD"},{"executeDate":"2020-02-27","recordDate":"2020-02-28","paymentDate":"2020-03-15","value":0.4296875,"currency":"USD"},{"executeDate":"2020-05-29","recordDate":"2020-06-01","paymentDate":"2020-06-15","value":0.4296875,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBC\",market:\"US\",delay:false,,,undefined,":{}}}